Back to CVE records
Critical 10.0Published Oct 14, 2026

CVE-2026-55572e107: SQL injection in alt_auth plugin (otherdb / e107db backends) via login username

Updated under an hour ago ()

Does this affect you?

It affects e107inc e107. Add what you run to find out whether that includes you.

EPSS puts the chance of exploitation in the next 30 days at 0.52%, higher than 43% of scored CVEs.

e107 is a content management system (CMS). Prior to 2.3.7, the bundled alt_auth plugin's otherdb and e107db authentication backends interpolate the submitted login username directly into SQL in e107_plugins/alt_auth/otherdb_auth.php and e107_plugins/alt_auth/e107db_auth.php. The login() methods execute those strings with PDO::query() before effective sanitization, so an unauthenticated user can inject SQL when alt_auth is installed and either backend is configured with a live external database connection. The injection can expose or modify data available to the configured database account, and query failures can additionally disclose the generated query through the debug-message path. This issue is fixed in version 2.3.7.

CVSS
10.0 CRITICAL (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H
Weakness (CWE)
CWE-89
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
0.52% (percentile 43)
Assigned by
GitHub_M
NVD analysis
Deferred
Record last updated
Oct 14, 2026
First seen by InfoSec Signals
Oct 14, 2026

Affected products

Affected products
e107inc e107
e107inc:e107 (from the name)
before 2.3.7
CNA record

References

  • x-refsource-confirm
  • x-refsource-misc
  • x-refsource-misc

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.